Presentations

Slides and handouts are frequently made available to delegates attending medical congresses. In an effort to provide additional value, slides are posted in our slide library, often associated with the topic covered in a report. As a certified healthcare professional, you may view the slides therein and download them for peer presentation or patient counselling purposes.

MEDICAL OPTIONS in Neuro-Oncology -

Currrent Trends and Future Perspectives in Glioblastoma Multiforme - Reviews from published literature

JOURNAL CLUB - Oncology - At the end of this report, you can view Prof. David Miles' ASCO presentation on the AVADO study.

Enhancing Progression-free Survival in Metastatic Breast Cancer: Efficacy of VEGF Inhibition and Taxane-based Therapy

PRIORITY PRESS - National Oncology Pharmacy Symposium 2008 - Calgary, Alberta / October 17-19, 2008

Prevention and Management of Chemotherapy-induced Nausea and Vomiting

PRIORITY PRESS - National Oncology Pharmacy Symposium 2008 - Calgary, Alberta / October 17-19, 2008

Prevention and Management of Chemotherapy-induced Nausea and Vomiting

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

Optimizing Targeted Therapy of Renal Cell Carcinoma

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

High Activity Rates Establish Targeted Therapies as Standard in Renal Cell Carcinoma and GIST

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients

33rd Congress of the European Society for Medical Oncology - Stockholm, Sweden / September 12-16, 2008

Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients

PAGE 5 OF 8   1 2 3 4 5 6 7 8